Overview
Familial lipoprotein lipase (LPL) deficiency is a rare inherited metabolic disorder that affects how your body breaks down fats (triglycerides) in the blood. It is also known as type I hyperlipoproteinemia, familial chylomicronemia syndrome, or hyperlipoproteinemia type Ia. In this condition, the enzyme lipoprotein lipase — which normally breaks down fat-carrying particles called chylomicrons — is either missing or does not work properly. As a result, triglyceride levels in the blood become extremely high, often exceeding 1,000 mg/dL and sometimes reaching over 10,000 mg/dL. The disease usually appears in infancy or early childhood. Key symptoms include repeated episodes of severe abdominal pain caused by inflammation of the pancreas (acute pancreatitis), an enlarged liver and spleen, yellowish fatty deposits under the skin (eruptive xanthomas), and milky-appearing blood due to the high fat content. Some patients also experience fatigue, poor appetite, and failure to thrive in childhood. Treatment has traditionally centered on a very strict low-fat diet, typically limiting dietary fat to 15–20 grams per day or less. Medium-chain triglyceride (MCT) oil supplements may be used because they are absorbed differently and do not require LPL for processing. In 2021, the FDA approved volanesorsen (Waylivra) for certain patients with familial chylomicronemia syndrome in some countries, though access varies. Gene therapy (alipogene tiparvovec, marketed as Glybera) was previously approved in Europe but has since been withdrawn from the market. Managing this condition requires lifelong dietary vigilance and close medical follow-up to prevent life-threatening pancreatitis episodes.
Also known as:
Key symptoms:
Severe abdominal pain from pancreatitisExtremely high triglyceride levels in the bloodMilky or creamy-looking blood (lipemia)Yellowish bumps on the skin (eruptive xanthomas)Enlarged liverEnlarged spleenNausea and vomitingPoor appetiteFailure to thrive in infants and childrenFatigue and low energyRecurrent episodes of pancreatitisAbdominal bloatingMemory or concentration difficulties (brain fog)
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
FDA & Trial Timeline
5 eventsShanghai Jiao Tong University School of Medicine — EARLY_PHASE1
CorrectSequence Therapeutics Co., Ltd — EARLY_PHASE1
Ionis Pharmaceuticals, Inc. — PHASE3
Ionis Pharmaceuticals, Inc. — PHASE3
Université de Sherbrooke — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Familial lipoprotein lipase deficiency.
5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesREDEMPLO
Unknown
Hyperchylomicronemia
Travel Grants
No travel grants are currently matched to Familial lipoprotein lipase deficiency.
Community
No community posts yet. Be the first to share your experience with Familial lipoprotein lipase deficiency.
Start the conversation →Latest news about Familial lipoprotein lipase deficiency
Disease timeline:
New recruiting trial: CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
A new clinical trial is recruiting patients for Familial lipoprotein lipase deficiency
New recruiting trial: Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
A new clinical trial is recruiting patients for Familial lipoprotein lipase deficiency
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What should my daily fat intake limit be, and can you refer me to a dietitian experienced with this condition?,What are the warning signs of pancreatitis, and what should I do if they occur?,Am I a candidate for volanesorsen or any other medication to help lower my triglycerides?,How often should I have blood tests to monitor my triglyceride levels and nutritional status?,Are there any clinical trials or new treatments being studied that I might be eligible for?,Should my family members be tested to see if they are carriers?,What fat-soluble vitamin and essential fatty acid supplements should I be taking?
Common questions about Familial lipoprotein lipase deficiency
What is Familial lipoprotein lipase deficiency?
Familial lipoprotein lipase (LPL) deficiency is a rare inherited metabolic disorder that affects how your body breaks down fats (triglycerides) in the blood. It is also known as type I hyperlipoproteinemia, familial chylomicronemia syndrome, or hyperlipoproteinemia type Ia. In this condition, the enzyme lipoprotein lipase — which normally breaks down fat-carrying particles called chylomicrons — is either missing or does not work properly. As a result, triglyceride levels in the blood become extremely high, often exceeding 1,000 mg/dL and sometimes reaching over 10,000 mg/dL. The disease usual
How is Familial lipoprotein lipase deficiency inherited?
Familial lipoprotein lipase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Familial lipoprotein lipase deficiency typically begin?
Typical onset of Familial lipoprotein lipase deficiency is infantile. Age of onset can vary across affected individuals.
Are there clinical trials for Familial lipoprotein lipase deficiency?
Yes — 5 recruiting clinical trials are currently listed for Familial lipoprotein lipase deficiency on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Familial lipoprotein lipase deficiency?
5 specialists and care centers treating Familial lipoprotein lipase deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Familial lipoprotein lipase deficiency?
1 patient support program are currently tracked on UniteRare for Familial lipoprotein lipase deficiency. See the treatments and support programs sections for copay assistance, eligibility, and contact details.